Back to Trades
Other4
Anika Therapeutics, Inc.
ANIK
Total Value
$0
Company Information
- Company Name
- Anika Therapeutics, Inc.
- Ticker Symbol
- ANIK
- CIK
- 0000898437
Insider Information
- Role
- Insider
- Location
- BEDFORD, MA
Filing Details
- Filing Date
- Feb 3, 2026
- Transaction Date
- Feb 1, 2026
- Accession Number
- 0001193125-26-036129
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 1, 2026 | Derivative | 310,207 | — | Grant/Award | — |
| Feb 1, 2026 | Derivative | 130,402 | — | Grant/Award | — |
Footnotes
- (F1)Includes 800 shares acquired on November 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
- (F2)The Stock Appreciation Right is payable in cash, shares of common stock, or a combination thereof, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended, and the applicable award agreement.
- (F3)Vests in three equal annual installments, with the first installment vesting on February 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.
- (F4)Each RSU represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended, and the applicable award agreement.